Delivery Order SPE2DB20D6037-SPE2DB24FTVA0

Award Date 4/1/24
Potential Completion Date 4/2/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,136.96 firm fixed-price contract is for the supply of the pharmaceutical product DEXTROAMP-AMPHET ER 20 MG CAP 100S. The contract has an ultimate completion date of July 11, 2023 and is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery...
This federal contract award, valued at $3,049.99, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of the pharmaceutical product Dextroamp-Amphet ER 10 mg capsules, with an ultimate completion date of March 13, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,692.64 contract is for the delivery of dextroamphetamine-amphetamine 10 milligram tablets, with a performance period through April 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, under which this specific delivery order was...
The U.S. Department of Defense (DoD), through its Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order valued at $1,651.68 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This order was placed under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA. The IDC, under the SPE2DB program, enables the DLA to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a total ceiling value of $57,317.20 and runs through September 10, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $121,467.90 and an ultimate completion date of January 22, 2025. The contract is not associated with any set-aside designations. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,892.90, is for the delivery of a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,360.58, is for the supply of Dextroamphetamine-Amphetamine 10 mg tablets to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order, with a performance period extending to February 6, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $2,545.03 and an ultimate completion date of May 13, 2024. The order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,952.99, is for the provision of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB24FTVA0
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $1,095.47, is for the supply of 4564135191 DEXTROAMP-AMPHET ER 10 MG CAP 100S.

The contract is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This IDC complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.

The contract does not have a set-aside designation and is for delivery through April 2, 2024.

Generated 10/23/24, 9:46 AM